口语
发表于 2025-3-21 16:04:09
书目名称Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0668404<br><br> <br><br>书目名称Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0668404<br><br> <br><br>书目名称Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0668404<br><br> <br><br>书目名称Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0668404<br><br> <br><br>书目名称Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0668404<br><br> <br><br>书目名称Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0668404<br><br> <br><br>书目名称Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0668404<br><br> <br><br>书目名称Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0668404<br><br> <br><br>书目名称Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0668404<br><br> <br><br>书目名称Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0668404<br><br> <br><br>
可行
发表于 2025-3-21 20:36:50
Preclinical and Clinical Development of Synthetic ,NKT-Cell Glycolipid Agonists as Vaccine Adjuvantsss a semi-invariant T-cell receptor (TCR), Vα14-Jα18 paired with Vβ8.2, Vβ7 or Vβ2 in mice and Vα24-Jα18/Vβ11 in human . These cells are referred to as .NKT cells type I NKT cells, or NKT cells, in contrast to type II NKT cells comprising the remaining NKT cells expressing non-invariant TCR
烧烤
发表于 2025-3-22 03:59:54
Mucosal Vaccination: Opportunities and Challengeson. Mucosal surfaces, with a combined surface area of about 400 m. , are undoubtedly the major site of entry for most pathogens. Therefore, these vulnerable surfaces are associated with a large and highly specialized innate and adaptive mucosal immune system that protects the surfaces and the bod
optic-nerve
发表于 2025-3-22 07:55:41
http://reply.papertrans.cn/67/6685/668404/668404_4.png
NEG
发表于 2025-3-22 12:24:18
http://reply.papertrans.cn/67/6685/668404/668404_5.png
FECT
发表于 2025-3-22 16:17:32
High Throughput Screening for Stabilizers of Vaccine Antigensed, its conversion into an efficacious, safe, convenient, and stable dosage form that can be effectively delivered to a target population is often beset with numerous difficulties. Not the least of these is the many different types of vaccine antigens, each with its own individual chemical identity,
LUDE
发表于 2025-3-22 17:40:02
http://reply.papertrans.cn/67/6685/668404/668404_7.png
accrete
发表于 2025-3-23 00:14:59
Current Status of Electroporation Technologies for Vaccine Deliveryby the plasmid and controlled by mammalian promoters, the stage was set for the investigation of the range of compelling applications for endogenous expression of proteins in animals and humans . The finding that simple injection of purified plasmid DNA into a target tissue could induce sustained
Excitotoxin
发表于 2025-3-23 02:46:17
Microneedles for Intradermal Vaccination: Immunopotentiation and Formulation Aspects. Ease of administration, improved immune protection, antigen dose sparing, and independence of cold-chain distribution are among the many potential benefits that the technology can introduce in the field . Due to the same advantages, microneedle-based vaccines, and intradermal vaccination in gen
ALIEN
发表于 2025-3-23 08:00:55
http://reply.papertrans.cn/67/6685/668404/668404_10.png